BlackRock Group’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $3.72M | Buy |
20,216
+6,999
| +53% | +$1.29M | ﹤0.01% | 1338 |
|
2016
Q3 | $3.41M | Buy |
13,217
+681
| +5% | +$175K | ﹤0.01% | 1289 |
|
2016
Q2 | $2.68M | Buy |
12,536
+856
| +7% | +$183K | ﹤0.01% | 1373 |
|
2016
Q1 | $2.41M | Buy |
11,680
+956
| +9% | +$197K | ﹤0.01% | 1419 |
|
2015
Q4 | $2.71M | Buy |
10,724
+132
| +1% | +$33.4K | ﹤0.01% | 1323 |
|
2015
Q3 | $1.74M | Sell |
10,592
-1,594
| -13% | -$262K | ﹤0.01% | 1572 |
|
2015
Q2 | $2.29M | Buy |
12,186
+7,642
| +168% | +$1.43M | ﹤0.01% | 1478 |
|
2015
Q1 | $750K | Buy |
4,544
+545
| +14% | +$90K | ﹤0.01% | 2015 |
|
2014
Q4 | $930K | Buy |
3,999
+140
| +4% | +$32.6K | ﹤0.01% | 1916 |
|
2014
Q3 | $698K | Buy |
3,859
+455
| +13% | +$82.3K | ﹤0.01% | 1987 |
|
2014
Q2 | $655K | Sell |
3,404
-4,450
| -57% | -$856K | ﹤0.01% | 2045 |
|
2014
Q1 | $1.43M | Buy |
7,854
+184
| +2% | +$33.5K | ﹤0.01% | 1784 |
|
2013
Q4 | $1.31M | Buy |
7,670
+336
| +5% | +$57.2K | ﹤0.01% | 1795 |
|
2013
Q3 | $1.15M | Hold |
7,334
| – | – | ﹤0.01% | 1811 |
|
2013
Q2 | $1.27M | Buy |
+7,334
| New | +$1.27M | ﹤0.01% | 1566 |
|